New Optimer contract to develop bioanalytical tools for RNA therapy

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, today announces the signing of a new development contract with a rare disease biopharmaceutical company.

NYU Langone IBD Center celebrates two years of transforming lives

A complex, chronic, and debilitating condition, inflammatory bowel disease (IBD) affects roughly 3 million Americans, including those with Crohn’s disease and ulcerative colitis.

December 16, 2024

Physician Explores Family’s End-of-Life Journey in New Podcast

As host of the TED Health podcast, Shoshana Ungerleider, MD, is no stranger to podcasting. But now, the internist turned the mic on herself to

November 5, 2024

Researchers develop faster, cheaper, and more precise method for identifying bacteria

Researchers have developed a method that identifies bacteria easily, cheaply and more precisely than before.

November 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.